Related Experiment Video
Updated: Jun 14, 2026
08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Anti-Inflammatory Agents for Cancer Therapy
Elizabeth R Rayburn1, Scharri J Ezell, Ruiwen Zhang
1Department of Pharmacology and Toxicology, Division of Clinical Pharmacology, University of Alabama at Birmingham, Birmingham, Alabama.
Molecular and Cellular Pharmacology
|March 25, 2010
Summary
Chronic inflammation is linked to cancer, and anti-inflammatory agents show promise for cancer prevention and therapy. Combining these agents with conventional treatments may improve outcomes.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Inflammation is closely associated with cancer development and progression.
- Chronic inflammation is a known risk factor for various cancers.
- Many anti-cancer drugs also possess anti-inflammatory properties.
Purpose of the Study:
- To explore the epidemiological evidence linking inflammation and cancer.
- To summarize the current applications of anti-inflammatory agents in cancer prevention and therapy.
- To elucidate the mechanisms of anti-cancer effects of anti-inflammatory agents.
Main Methods:
- Review of epidemiological studies on inflammation and cancer.
- Summary of clinical applications of anti-inflammatory agents in oncology.
- Analysis of mechanistic studies on anti-cancer properties of anti-inflammatory drugs.
Main Results:
- Epidemiological data strongly support the link between chronic inflammation and increased cancer risk.
- Anti-inflammatory agents are used in cancer prevention and therapy, with varying efficacy.
- Mechanisms include modulation of inflammatory pathways, immune response, and direct anti-tumor effects.
Conclusions:
- Eliminating inflammation is a potential strategy for cancer prevention and treatment.
- Combination therapy of anti-inflammatory agents with conventional cancer treatments warrants further investigation.
- Future research should focus on novel anti-cancer anti-inflammatory agents and their therapeutic potential.
More Related Videos
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...